For an estimated 30 million American adults, the simple act of breathing can be a daily struggle. That’s one in eight adults ...

AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

Labelling warns that certain nasal conditions, such as nasal polyps or a history of nasal surgery, may affect the absorption of the new drug. ARS said it will launch the product onto the market ...

There has been a road traffic colliison on the A12 Westlink, where it meets the Divis Street on-slip (heading to York Street). The Westlink is down to one lane with knock-on delays back to the M1 ...